Related Content
Download content relating to this event and topic.
Bringing together Antibody Engineering, TIDES of Innovation, and ADC Connect, the ANTIBODY & TIDES SUMMIT 2025 is where antibody power meets TIDES precision.
Coming together in an unprecedented event that will provide professionals with a comprehensive look at the most exciting developments in the biopharmaceutical industry, the Antibody & TIDES Summit 2025, will bring together senior leaders, top scientists, and decision-makers across peptide and oligonucleotide therapeutics, antibody engineering, and ADCs, offering a unique opportunity to address the latest challenges and advancements in biologic drug development, across three streams:
As the biopharma sector evolves, peptide and oligonucleotide therapeutics, antibody engineering, and ADCs are emerging as key areas of innovation. The TIDES of Innovation programme will tackle challenges in synthesis, regulation, and commercialisation of peptides and oligonucleotides. Antibody Engineering will explore advances in antibody production, including manufacturing optimisation, automation, and regulatory compliance. ADC Connect will focus on designing next-gen ADCs, AI integration, clinical case studies, and manufacturing hurdles.
The event will also feature networking and exhibition sessions, offering opportunities to engage with industry leaders and explore new technologies. By combining these three programmes, the summit delivers a comprehensive look at the future of biologics, making it a must-attend for professionals in biopharmaceutical development.
By integrating these three focused programmes this event provides a unique, holistic view of the biologics sector. With cutting-edge content, unparalleled networking opportunities, and in-depth discussions on the challenges and innovations across multiple biologic modalities, this summit is essential for anyone looking to stay ahead in the rapidly advancing world of biopharmaceutical development.
View the Key Themes for
Antibody & TIDES Summit 2025
Antibody engineering is revolutionising the treatment of complex diseases, such as cancer and autoimmune disorders. With the European market for monoclonal antibodies poised for significant growth, enhancing manufacturing processes has become more critical than ever. Antibody Engineering will provide a comprehensive platform for exploring the latest advancements in antibody production, including manufacturing optimisation, scale-up challenges, purification techniques, and regulatory compliance. Attendees will also engage in discussions around the integration of single-use technologies, automation, and computational approaches in antibody optimisation.
Day 1
Day 2
As the biopharmaceutical landscape continues to evolve, peptide and oligonucleotide therapeutics are gaining unprecedented momentum. These complex molecules are at the forefront of the next generation of targeted therapies, offering promising treatments for a variety of diseases, including cancer, cardiovascular conditions, and rare genetic disorders. However, the path from discovery to market for these therapeutics is fraught with unique challenges, particularly in terms of synthesis, scalability, regulatory approval, and commercialisation. TIDES of Innovation will address these challenges through specialised, high-level discussions on optimising synthesis, navigating regulatory landscapes, and developing effective strategies for commercial scale-up.
Designed for those at the forefront of this rapidly growing sector, this programme will offer an intimate setting for deep-dive conversations and networking opportunities:
Day 1
Day 2
ADC Connect focuses specifically on the rapidly-advancing field of antibody drug conjugates, covering critical topics in the design and engineering of ADCs, such as optimising payload-linker technologies and exploring novel ADC payloads to expand therapeutic potential.
The agenda will also address the integration of AI and computational tools in ADC development, along with next-generation ADCs and the promise of combination therapies. Regulatory considerations for ADC development, clinical development case studies, and the stability, safety, and pharmacokinetics of ADCs will also be discussed.
Manufacturing challenges and supply chain solutions for ADCs will be key themes, ensuring that participants are equipped with the insights needed to overcome the complex challenges in ADC production:
Day 1
Day 2
Register today to secure your ticket.
Our selected experts will share insights on the latest trends, challenges, and developments in this dynamic field. Engage in unique discussions, learn about cutting-edge scientific discoveries, and explore the future of biopharmaceuticals with these influential thought leaders.
Choose a plan that fits your role, company, and industry.
Early Bird
VAT exemptions will be applied where applicable in accordance with relevant regulations.
Early Bird
VAT exemptions will be applied where applicable in accordance with relevant regulations.
Representatives of service, solution, and technology providers are welcome to attend the Antibody & TIDES Summit 2025
Get in touch with us today for detailed information on attendee options, sponsorship opportunities and benefits, and how to maximise your presence at #TIDESxAB2025
Be the first in line! Register your interest now to get exclusive access to Super Early-Bird tickets - the lowest prices available - before they go live.
Join the roster of esteemed colleagues to discuss what you or your company are bringing to the biopharmaceutical industry.
Contact the IMAPAC to learn about our sponsorship process, rates and more.
Visit the event page to view more content.
Visit the awards page to view more content.
Download content relating to this event and topic.
Visit the event page to view more content.
To stay informed about event updates, including date, venue, and agenda, please subscribe to our newsletter on our event website. You can also follow our official social media channels for real-time updates and announcements.
The conference will provide a comprehensive learning experience covering various aspects of the dynamic biopharmaceutical industry, ensuring attendees gain valuable insights and knowledge.
We are committed to ensuring the safety and well-being of all attendees. We will implement rigorous safety measures in line with local health guidelines and regulations. Specific safety measures will be communicated closer to the event date to ensure they align with the most up-to-date health recommendations. Rest assured, your safety is our priority.
Yes, we have a cancellation and refund policy in place. Please refer to our “Cancellation Policy” on our website for details on how to request a refund if you are unable to attend.
We welcome presentation submissions. If you’re interested in speaking at the event, please visit this page on our website for submission guidelines and deadlines.
Our event is designed to cater to a wide range of professionals within the biopharmaceutical industry, including researchers, scientists, executives, regulatory experts, and professionals involved in drug development and manufacturing.
Participants can expect to gain insights from industry experts, network with peers, and stay up-to-date with the latest trends and innovations in biopharmaceuticals
Yes, we have networking sessions, workshops, and social events scheduled throughout the event to facilitate connections and collaborations among attendees.
Yes, we offer sponsorship and exhibition opportunities for businesses and organizations. Please visit our this page on our website for more information.
To register for the event, you'll find multiple "register" buttons on this page to get started. You’ll find detailed instructions and options for registration, including pricing and deadlines.
Don't miss out on unique networking, speaking and sponsorship opportunities.